THE EUROPEAN MEDICINES AGENCY has issued the following document:-
Covid-19 Vaccines Safety Update – 17th March 2022 states post vaccination concerns on the following:-
“Comirnaty” (Pfizer BioNtec)
“Janssens Covid-19” (Janssens-Cilag)
“Nuvaxovid” (Novax CZ)
“Spikevax” (Moderna Biotec BV)
“Vaxzevira” (Astrazeneca AB)
The full document is downloadable via EMA website. For Laptop & Desktop a more convenient the pdf is viewable below with relevant highlights in yellow and red lines. (example ’17 March 2022′ and ‘Safety Update’)
Further Readings:
Covid-19 Vaccines Safety Update – 17th March 2022 Source document by EMA (European Medical Agency)
No comments to show.